av/inflarx--big.svg

NASDAQ:IFRX

InflaRx

  • Stock

1.85

+8.82%

1.02

USD last updated 13/08 01:59:42

Last Close

0.83

12/08 20:00

Market Cap

95.39M

Beta: 0.92

Volume Today

388.95K

Avg: 2.53M

PE Ratio

−2.38

PFCF: −2.69

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a novel intravenously delivered first-...Show More

    Earnings

    Earnings per Share (Estimate*)

    -0.6-0.4-0.20.22017-03-312019-03-282020-10-292022-11-092024-05-08

    Revenue (Estimate*)

    1M2M3M4M5M6M2017-03-312019-03-282020-10-292022-11-092024-05-08

    *Estimate based on analyst consensus